Avanos Medical Stock Current Valuation
| 8HH Stock | EUR 17.60 0.20 1.15% |
Valuation analysis of Avanos Medical helps investors to measure Avanos Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Avanos Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Avanos Medical is based on 3 months time horizon. Increasing Avanos Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Avanos stock is determined by what a typical buyer is willing to pay for full or partial control of Avanos Medical. Since Avanos Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avanos Stock. However, Avanos Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.6 | Real 18.5 | Hype 17.6 | Naive 17.02 |
The real value of Avanos Stock, also known as its intrinsic value, is the underlying worth of Avanos Medical Company, which is reflected in its stock price. It is based on Avanos Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Avanos Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Avanos Medical helps investors to forecast how Avanos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avanos Medical more accurately as focusing exclusively on Avanos Medical's fundamentals will not take into account other important factors: Avanos Medical Company Current Valuation Analysis
Avanos Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Avanos Medical Current Valuation | 1.35 B |
Most of Avanos Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avanos Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Avanos Medical has a Current Valuation of 1.35 B. This is 90.6% lower than that of the Healthcare sector and 85.24% lower than that of the Medical Instruments & Supplies industry. The current valuation for all Germany stocks is 91.88% higher than that of the company.
Avanos Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avanos Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics of similar companies.Avanos Medical is currently under evaluation in current valuation category among its peers.
Avanos Fundamentals
| Return On Equity | 0.0348 | |||
| Return On Asset | 0.0236 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 46.5 M | |||
| Shares Owned By Insiders | 1.65 % | |||
| Shares Owned By Institutions | 95.00 % | |||
| Price To Earning | 108.36 X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 744.6 M | |||
| Gross Profit | 364.3 M | |||
| EBITDA | 47.4 M | |||
| Net Income | 5.2 M | |||
| Cash And Equivalents | 288.1 M | |||
| Cash Per Share | 6.05 X | |||
| Total Debt | 130 M | |||
| Debt To Equity | 25.60 % | |||
| Current Ratio | 3.06 X | |||
| Book Value Per Share | 27.11 X | |||
| Cash Flow From Operations | 87.3 M | |||
| Earnings Per Share | 0.87 X | |||
| Target Price | 43.0 | |||
| Number Of Employees | 4.55 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 1.32 B | |||
| Total Asset | 1.59 B | |||
| Z Score | 6.0 | |||
| Net Asset | 1.59 B |
About Avanos Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Avanos Stock
When determining whether Avanos Medical is a strong investment it is important to analyze Avanos Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avanos Medical's future performance. For an informed investment choice regarding Avanos Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Avanos Stock please use our How to Invest in Avanos Medical guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.